Education
About Us
Working with TipRanks
Follow Us
Allergy Therapeutics (GB:AGY)
:AGY
AGY Stock Chart & Stats
7.80p
-0.04p(-0.55%)
At close: 4:00 PM EST
7.80p
-0.04p(-0.55%)
Day’s Range― - ―
52-Week Range4.50p - 9.00p
Previous CloseN/A
Volume22.64K
Average Volume (3M)312.50K
Market Cap
£531.23M
Enterprise ValueN/A
Total Cash (Recent Filing)£21.68M
Total Debt (Recent Filing)£44.52M
Price to Earnings (P/E)―
Beta0.72
Next Earnings
Feb 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding6,141,440,000
10 Day Avg. Volume577,322
30 Day Avg. Volume312,502
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)47.44
Price to Sales (P/S)3.19
P/FCF Ratio-4.95
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Allergy Therapeutics News
AGY FAQ
What was Allergy Therapeutics’s price range in the past 12 months?
Allergy Therapeutics lowest share price was 4.50p and its highest was 9.00p in the past 12 months.
What is Allergy Therapeutics’s market cap?
Allergy Therapeutics’s market cap is £531.23M.
When is Allergy Therapeutics’s upcoming earnings report date?
Allergy Therapeutics’s upcoming earnings report date is Feb 26, 2026 which is in 115 days.
How were Allergy Therapeutics’s earnings last quarter?
Currently, no data Available
Is Allergy Therapeutics overvalued?
According to Wall Street analysts Allergy Therapeutics’s price is currently Overvalued.
Does Allergy Therapeutics pay dividends?
Allergy Therapeutics does not currently pay dividends.
What is Allergy Therapeutics’s EPS estimate?
Allergy Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Allergy Therapeutics have?
Allergy Therapeutics has 6,141,440,000 shares outstanding.
What happened to Allergy Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Allergy Therapeutics?
Currently, no hedge funds are holding shares in GB:AGY
Allergy Therapeutics Stock Smart Score
Company Description
Allergy Therapeutics
Allergy Therapeutics (AGY) is a leading biotechnology company specializing in the development and commercialization of allergy immunotherapy solutions. Operating within the healthcare and pharmaceuticals sector, the company focuses on transforming the treatment of allergies through innovative vaccines and treatments. Its core products are designed to provide long-term relief to patients suffering from various allergic conditions, significantly improving their quality of life.
Technical Analysis
Options Prices
Currently, No data available
---